MétaCan
Menu
Back to cohort

Similar 5-Year Survival after Peripheral Blood Autotransplants (AutoPB) Versus HLA Matched Sibling Myeloablative Transplants (AlloBMT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).

2008· article· en· W2493623723 on OpenAlexaff
Armand Keating, Manisha Kukreja, Gisela Tunes da Silva, Vikas Gupta, Corey Cutler, Martin S. Tallman, Jorge Sierra, John F. DiPersio, Mary M. Horowitz, Daniel J. Weisdorf

Bibliographic record

VenueBlood · 2008
Typearticle
Languageen
FieldMedicine
TopicAcute Myeloid Leukemia Research
Canadian institutionsPrincess Margaret Cancer Centre
Fundersnot available
KeywordsMedicineUnivariate analysisInternal medicineGastroenterologyMyeloid leukemiaBone marrowLeukemiaMedian follow-upSurgeryMultivariate analysisOncologyChemotherapy

Abstract

fetched live from OpenAlex

Abstract Optimum post-remission strategies for AML CR1 remain uncertain. Previous studies comparing autotransplants with alloBMT favored the latter because of less relapse despite treatment-related mortality (TRM) rates of 20–30%. In those studies, the autotransplants were exclusively with bone marrow (BM) and reported TRM of 12–20%. We were interested in determining the effect of lower TRM with AutoPB shown in many series to be 5–10%. We compared TRM, relapse, leukemia-free survival (LFS), and overall survival (OS) of 1133 patients 19–60 years of age in CR1 who underwent HLA-identical myeloablative BM or peripheral blood (PB) allogeneic transplants or AutoPB for AML reported to the CIBMTR from 1995–2004. For alloBM, alloPB and autoPB, median ages were 36, 40 and 44 yrs; cytogenetics were missing/unknown in 26%, 12% and 17%; proportion with poor risk cytogenetics was 6%, 9% and 7%; and median follow-up of survivors was 82 (6–149), 60 (4–144), and 62 (1–139) mo., respectively. Outcomes were evaluated in univariate and by multivariate analyses using the pseudo-value technique. Results: 5 year transplant outcomes by univariate analysis are as follows: Allo BM Allo PB Auto PB Outcomes@5years N Prob (95%CI) N Prob (95%CI) N Prob (95%CI) P-value Relapse 473 20 (17–24) 425 26 (21–30) 227 45 (38–52) <0.001 TRM 473 19 (16–23) 425 20 (17–24) 227 8 (5–12) <0.001 LFS 473 61 (56–65) 425 54 (49–59) 227 47 (40–54) 0.13 Survival 475 64 (59–68) 428 59 (54–64) 230 54 (47–60) 0.19 All analyses showed that risks associated with alloBM and AlloPB were identical, hence relative risk (RR) was modeled for any allotransplant (alloBMT) vs autoPB. Multivariate analysis of alloBMT vs autoPB cohorts revealed that age >40 yrs was associated with increased RR for TRM, LFS and OS at 5yrs:1.39 (1.05–1.84;n=518;p=0.019);1.25(1.04– 1.51;n=521;p=0.015);1.28(1.05–1.56;n=521;p= 0.012), respectively. For relapse at 5 yrs, the presence of extramedullary disease was a poor prognostic factor: [RR: 1.60 (1.13– 2.27); for no n=1036; yes n=88]. Cytogenetics risk category was not a significant covariate for TRM (p=0.84), relapse (p=0.13), LFS (p=0.27) or OS (p=0.062) at 5 yrs. Conclusions: AutoPB may provide acceptable alternative post-remission therapy for AML CR1 in the absence of a matched sibling donor, and its role in this regard should be reinvestigated prospectively.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.039
GPT teacher head0.294
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2008
Admission routes1
Has abstractyes

Explore more

Same venueBloodSame topicAcute Myeloid Leukemia ResearchFrench-language works237,207